150 related articles for article (PubMed ID: 9526953)
21. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
Morishita E; Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Hashimoto T; Matsuda T
Atherosclerosis; 1996 Feb; 120(1-2):7-14. PubMed ID: 8645373
[TBL] [Abstract][Full Text] [Related]
22. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
[TBL] [Abstract][Full Text] [Related]
23. Haemostatic variables in patients with unstable angina.
al-Nozha M; Gader AM; al-Momen AK; Noah MS; Jawaid M; Arafa M
Int J Cardiol; 1994 Mar; 43(3):269-77. PubMed ID: 8181885
[TBL] [Abstract][Full Text] [Related]
24. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
25. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
26. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
27. Aortic spontaneous echocardiographic contrast and hemostatic markers in patients with nonrheumatic atrial fibrillation.
Nakagawa K; Hirai T; Shinokawa N; Takashima S; Nozawa T; Asanoi H; Inoue H
Chest; 2002 Feb; 121(2):500-5. PubMed ID: 11834664
[TBL] [Abstract][Full Text] [Related]
28. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
Nichols AB; Owen J; Kaplan KL; Sciacca RR; Cannon PJ; Nossel HL
Blood; 1982 Sep; 60(3):650-4. PubMed ID: 6179552
[TBL] [Abstract][Full Text] [Related]
29. [Clinical tests on the diagnosis of thrombosis].
Yamanaka M
Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
[No Abstract] [Full Text] [Related]
30. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J
Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332
[TBL] [Abstract][Full Text] [Related]
31. ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies.
Papp AC; Hatzakis H; Bracey A; Wu KK
Thromb Haemost; 1989 Feb; 61(1):15-9. PubMed ID: 2526384
[TBL] [Abstract][Full Text] [Related]
32. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
[TBL] [Abstract][Full Text] [Related]
33. Coagulation and fibrinolysis markers in seminal plasma of patients under evaluation for involuntary childlessness.
van Wersch JW; De Vries-Hanje JC; Ubachs JM
Eur J Clin Chem Clin Biochem; 1992 Aug; 30(8):467-71. PubMed ID: 1445960
[TBL] [Abstract][Full Text] [Related]
34. Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers.
Sturzenegger M; Beer JH; Rihs F
Stroke; 1995 Jan; 26(1):63-9. PubMed ID: 7839399
[TBL] [Abstract][Full Text] [Related]
35. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
[TBL] [Abstract][Full Text] [Related]
36. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
37. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
38. Increased intravascular coagulation associated with pregnancy.
Gerbasi FR; Bottoms S; Farag A; Mammen E
Obstet Gynecol; 1990 Mar; 75(3 Pt 1):385-9. PubMed ID: 2137574
[TBL] [Abstract][Full Text] [Related]
39. Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT).
Seeber C; Hiller E; Holler E; Kolb HJ
Thromb Res; 1992 May; 66(4):373-83. PubMed ID: 1412203
[TBL] [Abstract][Full Text] [Related]
40. [New clinical tests that physicians should know for diagnosis of hematologic diseases].
Maruyama I
Nihon Naika Gakkai Zasshi; 1998 Oct; 87(10):2016-22. PubMed ID: 9867010
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
